July 9, 2018 Price forecast | 2 weeks: 3.78% | 1 month: 3.91% | 3 months: 3.94%


DERM stock forecast

Our latest prediction for Dermira, Inc.'s stock price was made on the July 9, 2018 when the stock price was at 10.42$.

In the short term (2weeks), DERM's stock price should outperform the market by 3.78%. During that period the price should oscillate between -10.05% and +14.49%.

In the medium term (3months), DERM's stock price should outperform the market by 3.94%. During that period the price should oscillate between -22.42% and +35.22%.


About Dermira, Inc.

Dermira, Inc. is a biopharmaceutical company, which engages in the provision of therapies for chronic skin conditions. It focuses on the development of therapeutic solutions in medical dermatology to treat skin conditions, such as hyperhidrosis and atopic dermatitis. The company was founded by Thomas G. Wiggans, Eugene Andrew Bauer, Luis C. Peña, and Christopher M. Griffith on August 18, 2010 and is headquartered in Menlo Park, CA.

At the moment the company generates 83M USD in revenues.

On its last earning announcement, the company reported a loss of -4.47$ per share.

The book value per share is 2.68$

Dermira, Inc. website


Three months stock forecastJuly 9, 2018


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
83M 93.80% -204M -245.90% -212M -4.47 - - 49M 2.68 -215M -30M -245M